No quarterly revenue total was found in Freenome, Inc.'s SEC filings.
Freenome, Inc. (FRNM) files with the SEC under industry code 8071, Services-Medical Laboratories.
Revenue
—
Net income
$-114,943
-115.2% vs year-ago quarter
Operating cash flow
$-129,810
+12.0% vs year-ago quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
8.91M
+0.0% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- FRNM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Brisbane, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2017526
- Former names
- Perceptive Capital Solutions Corp (until Jul 15, 2026)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$941,325 | -$858,834 | -$1.7M | -$856,160 | -$193,196 |
| Net income | -$114,943 | -$51,749 | -$740,568 | $144,634 | $754,847 |
| Operating cash flow | -$129,810 | -$297,852 | -$312,878 | -$166,500 | -$147,528 |
| Total assets | $85.8M | $93.3M | $92.8M | $92.2M | $91.4M |
| Total liabilities | $7.1M | $6.3M | $5.7M | $4.4M | $3.7M |
| Stockholders' equity | -$6.3M | -$5.7M | -$4.8M | -$3.1M | -$2.3M |
| Cash and investments | $437,369 | $567,179 | $865,031 | $1.2M | $1.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 20, 2026 | Oct 20, 2026 |
| 8-K/A |
Amended current report
Acquisition or sale of assets
|
Aug 13, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 27, 2026 | Jul 27, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jul 24, 2026 | Jul 20, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jul 15, 2026 | Jul 15, 2026 |
| 10-Q | Quarterly report | Jul 15, 2026 | Jun 30, 2026 |
All 135 Freenome, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.